Global IL-12 Antibody Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global IL-12 Antibody Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 90

Published Date: 12 Oct 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The IL-12 Antibody market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global IL-12 Antibody size is estimated to be USD million in 2026 from USD million in 2020, with a change % between 2020 and 2021. The global IL-12 Antibody market size is expected to grow at a CAGR of % for the next five years.

Market segmentation
IL-12 Antibody market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Polyclonal
Monoclonal

Market segment by Application, can be divided into
Flow Cytometry
Immunoprecipitation
Western Blot
Others

Market segment by players, this report covers
Thermo Fisher Scientific
FineTest
Santa Cruz Biotechnology
ProSci
Bio X Cell
GeneTex
Atlas Antibodies
Miltenyi Biotec
Proteintech
United States Biological
BioLegend
NSJ Bioreagents

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe IL-12 Antibody product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of IL-12 Antibody, with revenue, gross margin and global market share of IL-12 Antibody from 2019 to 2021.
Chapter 3, the IL-12 Antibody competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and IL-12 Antibody market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe IL-12 Antibody research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of IL-12 Antibody
1.2 Classification of IL-12 Antibody by Type
1.2.1 Overview: Global IL-12 Antibody Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global IL-12 Antibody Revenue Market Share by Type in 2020
1.2.3 Polyclonal
1.2.4 Monoclonal
1.3 Global IL-12 Antibody Market by Application
1.3.1 Overview: Global IL-12 Antibody Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Flow Cytometry
1.3.3 Immunoprecipitation
1.3.4 Western Blot
1.3.5 Others
1.4 Global IL-12 Antibody Market Size & Forecast
1.5 Global IL-12 Antibody Market Size and Forecast by Region
1.5.1 Global IL-12 Antibody Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global IL-12 Antibody Market Size by Region, (2016-2021)
1.5.3 North America IL-12 Antibody Market Size and Prospect (2016-2026)
1.5.4 Europe IL-12 Antibody Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific IL-12 Antibody Market Size and Prospect (2016-2026)
1.5.6 South America IL-12 Antibody Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa IL-12 Antibody Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 IL-12 Antibody Market Drivers
1.6.2 IL-12 Antibody Market Restraints
1.6.3 IL-12 Antibody Trends Analysis

2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific IL-12 Antibody Product and Solutions
2.1.4 Thermo Fisher Scientific IL-12 Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 FineTest
2.2.1 FineTest Details
2.2.2 FineTest Major Business
2.2.3 FineTest IL-12 Antibody Product and Solutions
2.2.4 FineTest IL-12 Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 FineTest Recent Developments and Future Plans
2.3 Santa Cruz Biotechnology
2.3.1 Santa Cruz Biotechnology Details
2.3.2 Santa Cruz Biotechnology Major Business
2.3.3 Santa Cruz Biotechnology IL-12 Antibody Product and Solutions
2.3.4 Santa Cruz Biotechnology IL-12 Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Santa Cruz Biotechnology Recent Developments and Future Plans
2.4 ProSci
2.4.1 ProSci Details
2.4.2 ProSci Major Business
2.4.3 ProSci IL-12 Antibody Product and Solutions
2.4.4 ProSci IL-12 Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 ProSci Recent Developments and Future Plans
2.5 Bio X Cell
2.5.1 Bio X Cell Details
2.5.2 Bio X Cell Major Business
2.5.3 Bio X Cell IL-12 Antibody Product and Solutions
2.5.4 Bio X Cell IL-12 Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Bio X Cell Recent Developments and Future Plans
2.6 GeneTex
2.6.1 GeneTex Details
2.6.2 GeneTex Major Business
2.6.3 GeneTex IL-12 Antibody Product and Solutions
2.6.4 GeneTex IL-12 Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 GeneTex Recent Developments and Future Plans
2.7 Atlas Antibodies
2.7.1 Atlas Antibodies Details
2.7.2 Atlas Antibodies Major Business
2.7.3 Atlas Antibodies IL-12 Antibody Product and Solutions
2.7.4 Atlas Antibodies IL-12 Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Atlas Antibodies Recent Developments and Future Plans
2.8 Miltenyi Biotec
2.8.1 Miltenyi Biotec Details
2.8.2 Miltenyi Biotec Major Business
2.8.3 Miltenyi Biotec IL-12 Antibody Product and Solutions
2.8.4 Miltenyi Biotec IL-12 Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Miltenyi Biotec Recent Developments and Future Plans
2.9 Proteintech
2.9.1 Proteintech Details
2.9.2 Proteintech Major Business
2.9.3 Proteintech IL-12 Antibody Product and Solutions
2.9.4 Proteintech IL-12 Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Proteintech Recent Developments and Future Plans
2.10 United States Biological
2.10.1 United States Biological Details
2.10.2 United States Biological Major Business
2.10.3 United States Biological IL-12 Antibody Product and Solutions
2.10.4 United States Biological IL-12 Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 United States Biological Recent Developments and Future Plans
2.11 BioLegend
2.11.1 BioLegend Details
2.11.2 BioLegend Major Business
2.11.3 BioLegend IL-12 Antibody Product and Solutions
2.11.4 BioLegend IL-12 Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 BioLegend Recent Developments and Future Plans
2.12 NSJ Bioreagents
2.12.1 NSJ Bioreagents Details
2.12.2 NSJ Bioreagents Major Business
2.12.3 NSJ Bioreagents IL-12 Antibody Product and Solutions
2.12.4 NSJ Bioreagents IL-12 Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 NSJ Bioreagents Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global IL-12 Antibody Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 IL-12 Antibody Players Market Share
3.2.2 Top 10 IL-12 Antibody Players Market Share
3.2.3 Market Competition Trend
3.3 IL-12 Antibody Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
4.1 Global IL-12 Antibody Revenue and Market Share by Type (2016-2021)
4.2 Global IL-12 Antibody Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
5.1 Global IL-12 Antibody Revenue Market Share by Application (2016-2021)
5.2 IL-12 Antibody Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
6.1 North America IL-12 Antibody Revenue by Type (2016-2026)
6.2 North America IL-12 Antibody Revenue by Application (2016-2026)
6.3 North America IL-12 Antibody Market Size by Country
6.3.1 North America IL-12 Antibody Revenue by Country (2016-2026)
6.3.2 United States IL-12 Antibody Market Size and Forecast (2016-2026)
6.3.3 Canada IL-12 Antibody Market Size and Forecast (2016-2026)
6.3.4 Mexico IL-12 Antibody Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
7.1 Europe IL-12 Antibody Revenue by Type (2016-2026)
7.2 Europe IL-12 Antibody Revenue by Application (2016-2026)
7.3 Europe IL-12 Antibody Market Size by Country
7.3.1 Europe IL-12 Antibody Revenue by Country (2016-2026)
7.3.2 Germany IL-12 Antibody Market Size and Forecast (2016-2026)
7.3.3 France IL-12 Antibody Market Size and Forecast (2016-2026)
7.3.4 United Kingdom IL-12 Antibody Market Size and Forecast (2016-2026)
7.3.5 Russia IL-12 Antibody Market Size and Forecast (2016-2026)
7.3.6 Italy IL-12 Antibody Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific IL-12 Antibody Revenue by Type (2016-2026)
8.2 Asia-Pacific IL-12 Antibody Revenue by Application (2016-2026)
8.3 Asia-Pacific IL-12 Antibody Market Size by Region
8.3.1 Asia-Pacific IL-12 Antibody Revenue by Region (2016-2026)
8.3.2 China IL-12 Antibody Market Size and Forecast (2016-2026)
8.3.3 Japan IL-12 Antibody Market Size and Forecast (2016-2026)
8.3.4 South Korea IL-12 Antibody Market Size and Forecast (2016-2026)
8.3.5 India IL-12 Antibody Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia IL-12 Antibody Market Size and Forecast (2016-2026)
8.3.7 Australia IL-12 Antibody Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
9.1 South America IL-12 Antibody Revenue by Type (2016-2026)
9.2 South America IL-12 Antibody Revenue by Application (2016-2026)
9.3 South America IL-12 Antibody Market Size by Country
9.3.1 South America IL-12 Antibody Revenue by Country (2016-2026)
9.3.2 Brazil IL-12 Antibody Market Size and Forecast (2016-2026)
9.3.3 Argentina IL-12 Antibody Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa IL-12 Antibody Revenue by Type (2016-2026)
10.2 Middle East & Africa IL-12 Antibody Revenue by Application (2016-2026)
10.3 Middle East & Africa IL-12 Antibody Market Size by Country
10.3.1 Middle East & Africa IL-12 Antibody Revenue by Country (2016-2026)
10.3.2 Turkey IL-12 Antibody Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia IL-12 Antibody Market Size and Forecast (2016-2026)
10.3.4 UAE IL-12 Antibody Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global IL-12 Antibody Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global IL-12 Antibody Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market IL-12 Antibody Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global IL-12 Antibody Revenue (USD Million) by Region (2016-2021)
Table 5. Global IL-12 Antibody Revenue Market Share by Region (2021-2026)
Table 6. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 7. Thermo Fisher Scientific Major Business
Table 8. Thermo Fisher Scientific IL-12 Antibody Product and Solutions
Table 9. Thermo Fisher Scientific IL-12 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. FineTest Corporate Information, Head Office, and Major Competitors
Table 11. FineTest Major Business
Table 12. FineTest IL-12 Antibody Product and Solutions
Table 13. FineTest IL-12 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Santa Cruz Biotechnology Corporate Information, Head Office, and Major Competitors
Table 15. Santa Cruz Biotechnology Major Business
Table 16. Santa Cruz Biotechnology IL-12 Antibody Product and Solutions
Table 17. Santa Cruz Biotechnology IL-12 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. ProSci Corporate Information, Head Office, and Major Competitors
Table 19. ProSci Major Business
Table 20. ProSci IL-12 Antibody Product and Solutions
Table 21. ProSci IL-12 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Bio X Cell Corporate Information, Head Office, and Major Competitors
Table 23. Bio X Cell Major Business
Table 24. Bio X Cell IL-12 Antibody Product and Solutions
Table 25. Bio X Cell IL-12 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. GeneTex Corporate Information, Head Office, and Major Competitors
Table 27. GeneTex Major Business
Table 28. GeneTex IL-12 Antibody Product and Solutions
Table 29. GeneTex IL-12 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Atlas Antibodies Corporate Information, Head Office, and Major Competitors
Table 31. Atlas Antibodies Major Business
Table 32. Atlas Antibodies IL-12 Antibody Product and Solutions
Table 33. Atlas Antibodies IL-12 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Miltenyi Biotec Corporate Information, Head Office, and Major Competitors
Table 35. Miltenyi Biotec Major Business
Table 36. Miltenyi Biotec IL-12 Antibody Product and Solutions
Table 37. Miltenyi Biotec IL-12 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Proteintech Corporate Information, Head Office, and Major Competitors
Table 39. Proteintech Major Business
Table 40. Proteintech IL-12 Antibody Product and Solutions
Table 41. Proteintech IL-12 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. United States Biological Corporate Information, Head Office, and Major Competitors
Table 43. United States Biological Major Business
Table 44. United States Biological IL-12 Antibody Product and Solutions
Table 45. United States Biological IL-12 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. BioLegend Corporate Information, Head Office, and Major Competitors
Table 47. BioLegend Major Business
Table 48. BioLegend IL-12 Antibody Product and Solutions
Table 49. BioLegend IL-12 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. NSJ Bioreagents Corporate Information, Head Office, and Major Competitors
Table 51. NSJ Bioreagents Major Business
Table 52. NSJ Bioreagents IL-12 Antibody Product and Solutions
Table 53. NSJ Bioreagents IL-12 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global IL-12 Antibody Revenue (USD Million) by Players (2019-2021)
Table 55. Global IL-12 Antibody Revenue Share by Players (2019-2021)
Table 56. Breakdown of IL-12 Antibody by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. IL-12 Antibody Players Head Office, Products and Services Provided
Table 58. IL-12 Antibody Mergers & Acquisitions in the Past Five Years
Table 59. IL-12 Antibody New Entrants and Expansion Plans
Table 60. Global IL-12 Antibody Revenue (USD Million) by Type (2016-2021)
Table 61. Global IL-12 Antibody Revenue Share by Type (2016-2021)
Table 62. Global IL-12 Antibody Revenue Forecast by Type (2021-2026)
Table 63. Global IL-12 Antibody Revenue by Application (2016-2021)
Table 64. Global IL-12 Antibody Revenue Forecast by Application (2021-2026)
Table 65. North America IL-12 Antibody Revenue by Type (2016-2021) & (USD Million)
Table 66. North America IL-12 Antibody Revenue by Type (2021-2026) & (USD Million)
Table 67. North America IL-12 Antibody Revenue by Application (2016-2021) & (USD Million)
Table 68. North America IL-12 Antibody Revenue by Application (2021-2026) & (USD Million)
Table 69. North America IL-12 Antibody Revenue by Country (2016-2021) & (USD Million)
Table 70. North America IL-12 Antibody Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe IL-12 Antibody Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe IL-12 Antibody Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe IL-12 Antibody Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe IL-12 Antibody Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe IL-12 Antibody Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe IL-12 Antibody Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific IL-12 Antibody Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific IL-12 Antibody Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific IL-12 Antibody Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific IL-12 Antibody Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific IL-12 Antibody Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific IL-12 Antibody Revenue by Region (2021-2026) & (USD Million)
Table 83. South America IL-12 Antibody Revenue by Type (2016-2021) & (USD Million)
Table 84. South America IL-12 Antibody Revenue by Type (2021-2026) & (USD Million)
Table 85. South America IL-12 Antibody Revenue by Application (2016-2021) & (USD Million)
Table 86. South America IL-12 Antibody Revenue by Application (2021-2026) & (USD Million)
Table 87. South America IL-12 Antibody Revenue by Country (2016-2021) & (USD Million)
Table 88. South America IL-12 Antibody Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa IL-12 Antibody Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa IL-12 Antibody Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa IL-12 Antibody Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa IL-12 Antibody Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa IL-12 Antibody Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa IL-12 Antibody Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. IL-12 Antibody Picture
Figure 2. Global IL-12 Antibody Revenue Market Share by Type in 2020
Figure 3. Polyclonal
Figure 4. Monoclonal
Figure 5. IL-12 Antibody Revenue Market Share by Application in 2020
Figure 6. Flow Cytometry Picture
Figure 7. Immunoprecipitation Picture
Figure 8. Western Blot Picture
Figure 9. Others Picture
Figure 10. Global IL-12 Antibody Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global IL-12 Antibody Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global IL-12 Antibody Revenue Market Share by Region (2016-2026)
Figure 13. Global IL-12 Antibody Revenue Market Share by Region in 2020
Figure 14. North America IL-12 Antibody Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe IL-12 Antibody Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific IL-12 Antibody Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America IL-12 Antibody Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa IL-12 Antibody Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. IL-12 Antibody Market Drivers
Figure 20. IL-12 Antibody Market Restraints
Figure 21. IL-12 Antibody Market Trends
Figure 22. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 23. FineTest Recent Developments and Future Plans
Figure 24. Santa Cruz Biotechnology Recent Developments and Future Plans
Figure 25. ProSci Recent Developments and Future Plans
Figure 26. Bio X Cell Recent Developments and Future Plans
Figure 27. GeneTex Recent Developments and Future Plans
Figure 28. Atlas Antibodies Recent Developments and Future Plans
Figure 29. Miltenyi Biotec Recent Developments and Future Plans
Figure 30. Proteintech Recent Developments and Future Plans
Figure 31. United States Biological Recent Developments and Future Plans
Figure 32. BioLegend Recent Developments and Future Plans
Figure 33. NSJ Bioreagents Recent Developments and Future Plans
Figure 34. Global IL-12 Antibody Revenue Share by Players in 2020
Figure 35. IL-12 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players IL-12 Antibody Revenue Market Share in 2020
Figure 37. Global Top 10 Players IL-12 Antibody Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global IL-12 Antibody Revenue Share by Type in 2020
Figure 40. Global IL-12 Antibody Market Share Forecast by Type (2021-2026)
Figure 41. Global IL-12 Antibody Revenue Share by Application in 2020
Figure 42. Global IL-12 Antibody Market Share Forecast by Application (2021-2026)
Figure 43. North America IL-12 Antibody Sales Market Share by Type (2016-2026)
Figure 44. North America IL-12 Antibody Sales Market Share by Application (2016-2026)
Figure 45. North America IL-12 Antibody Revenue Market Share by Country (2016-2026)
Figure 46. United States IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe IL-12 Antibody Sales Market Share by Type (2016-2026)
Figure 50. Europe IL-12 Antibody Sales Market Share by Application (2016-2026)
Figure 51. Europe IL-12 Antibody Revenue Market Share by Country (2016-2026)
Figure 52. Germany IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific IL-12 Antibody Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific IL-12 Antibody Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific IL-12 Antibody Revenue Market Share by Region (2016-2026)
Figure 60. China IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America IL-12 Antibody Sales Market Share by Type (2016-2026)
Figure 67. South America IL-12 Antibody Sales Market Share by Application (2016-2026)
Figure 68. South America IL-12 Antibody Revenue Market Share by Country (2016-2026)
Figure 69. Brazil IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa IL-12 Antibody Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa IL-12 Antibody Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa IL-12 Antibody Revenue Market Share by Country (2016-2026)
Figure 74. Turkey IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Thermo Fisher Scientific
FineTest
Santa Cruz Biotechnology
ProSci
Bio X Cell
GeneTex
Atlas Antibodies
Miltenyi Biotec
Proteintech
United States Biological
BioLegend
NSJ Bioreagents
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global IL-12 Antibody Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global IL-12 Antibody Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 90

Published Date: 12 Oct 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The IL-12 Antibody market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global IL-12 Antibody size is estimated to be USD million in 2026 from USD million in 2020, with a change % between 2020 and 2021. The global IL-12 Antibody market size is expected to grow at a CAGR of % for the next five years.

Market segmentation
IL-12 Antibody market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Polyclonal
Monoclonal

Market segment by Application, can be divided into
Flow Cytometry
Immunoprecipitation
Western Blot
Others

Market segment by players, this report covers
Thermo Fisher Scientific
FineTest
Santa Cruz Biotechnology
ProSci
Bio X Cell
GeneTex
Atlas Antibodies
Miltenyi Biotec
Proteintech
United States Biological
BioLegend
NSJ Bioreagents

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe IL-12 Antibody product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of IL-12 Antibody, with revenue, gross margin and global market share of IL-12 Antibody from 2019 to 2021.
Chapter 3, the IL-12 Antibody competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and IL-12 Antibody market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe IL-12 Antibody research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of IL-12 Antibody
1.2 Classification of IL-12 Antibody by Type
1.2.1 Overview: Global IL-12 Antibody Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global IL-12 Antibody Revenue Market Share by Type in 2020
1.2.3 Polyclonal
1.2.4 Monoclonal
1.3 Global IL-12 Antibody Market by Application
1.3.1 Overview: Global IL-12 Antibody Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Flow Cytometry
1.3.3 Immunoprecipitation
1.3.4 Western Blot
1.3.5 Others
1.4 Global IL-12 Antibody Market Size & Forecast
1.5 Global IL-12 Antibody Market Size and Forecast by Region
1.5.1 Global IL-12 Antibody Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global IL-12 Antibody Market Size by Region, (2016-2021)
1.5.3 North America IL-12 Antibody Market Size and Prospect (2016-2026)
1.5.4 Europe IL-12 Antibody Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific IL-12 Antibody Market Size and Prospect (2016-2026)
1.5.6 South America IL-12 Antibody Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa IL-12 Antibody Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 IL-12 Antibody Market Drivers
1.6.2 IL-12 Antibody Market Restraints
1.6.3 IL-12 Antibody Trends Analysis

2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific IL-12 Antibody Product and Solutions
2.1.4 Thermo Fisher Scientific IL-12 Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 FineTest
2.2.1 FineTest Details
2.2.2 FineTest Major Business
2.2.3 FineTest IL-12 Antibody Product and Solutions
2.2.4 FineTest IL-12 Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 FineTest Recent Developments and Future Plans
2.3 Santa Cruz Biotechnology
2.3.1 Santa Cruz Biotechnology Details
2.3.2 Santa Cruz Biotechnology Major Business
2.3.3 Santa Cruz Biotechnology IL-12 Antibody Product and Solutions
2.3.4 Santa Cruz Biotechnology IL-12 Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Santa Cruz Biotechnology Recent Developments and Future Plans
2.4 ProSci
2.4.1 ProSci Details
2.4.2 ProSci Major Business
2.4.3 ProSci IL-12 Antibody Product and Solutions
2.4.4 ProSci IL-12 Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 ProSci Recent Developments and Future Plans
2.5 Bio X Cell
2.5.1 Bio X Cell Details
2.5.2 Bio X Cell Major Business
2.5.3 Bio X Cell IL-12 Antibody Product and Solutions
2.5.4 Bio X Cell IL-12 Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Bio X Cell Recent Developments and Future Plans
2.6 GeneTex
2.6.1 GeneTex Details
2.6.2 GeneTex Major Business
2.6.3 GeneTex IL-12 Antibody Product and Solutions
2.6.4 GeneTex IL-12 Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 GeneTex Recent Developments and Future Plans
2.7 Atlas Antibodies
2.7.1 Atlas Antibodies Details
2.7.2 Atlas Antibodies Major Business
2.7.3 Atlas Antibodies IL-12 Antibody Product and Solutions
2.7.4 Atlas Antibodies IL-12 Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Atlas Antibodies Recent Developments and Future Plans
2.8 Miltenyi Biotec
2.8.1 Miltenyi Biotec Details
2.8.2 Miltenyi Biotec Major Business
2.8.3 Miltenyi Biotec IL-12 Antibody Product and Solutions
2.8.4 Miltenyi Biotec IL-12 Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Miltenyi Biotec Recent Developments and Future Plans
2.9 Proteintech
2.9.1 Proteintech Details
2.9.2 Proteintech Major Business
2.9.3 Proteintech IL-12 Antibody Product and Solutions
2.9.4 Proteintech IL-12 Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Proteintech Recent Developments and Future Plans
2.10 United States Biological
2.10.1 United States Biological Details
2.10.2 United States Biological Major Business
2.10.3 United States Biological IL-12 Antibody Product and Solutions
2.10.4 United States Biological IL-12 Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 United States Biological Recent Developments and Future Plans
2.11 BioLegend
2.11.1 BioLegend Details
2.11.2 BioLegend Major Business
2.11.3 BioLegend IL-12 Antibody Product and Solutions
2.11.4 BioLegend IL-12 Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 BioLegend Recent Developments and Future Plans
2.12 NSJ Bioreagents
2.12.1 NSJ Bioreagents Details
2.12.2 NSJ Bioreagents Major Business
2.12.3 NSJ Bioreagents IL-12 Antibody Product and Solutions
2.12.4 NSJ Bioreagents IL-12 Antibody Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 NSJ Bioreagents Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global IL-12 Antibody Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 IL-12 Antibody Players Market Share
3.2.2 Top 10 IL-12 Antibody Players Market Share
3.2.3 Market Competition Trend
3.3 IL-12 Antibody Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
4.1 Global IL-12 Antibody Revenue and Market Share by Type (2016-2021)
4.2 Global IL-12 Antibody Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
5.1 Global IL-12 Antibody Revenue Market Share by Application (2016-2021)
5.2 IL-12 Antibody Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
6.1 North America IL-12 Antibody Revenue by Type (2016-2026)
6.2 North America IL-12 Antibody Revenue by Application (2016-2026)
6.3 North America IL-12 Antibody Market Size by Country
6.3.1 North America IL-12 Antibody Revenue by Country (2016-2026)
6.3.2 United States IL-12 Antibody Market Size and Forecast (2016-2026)
6.3.3 Canada IL-12 Antibody Market Size and Forecast (2016-2026)
6.3.4 Mexico IL-12 Antibody Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
7.1 Europe IL-12 Antibody Revenue by Type (2016-2026)
7.2 Europe IL-12 Antibody Revenue by Application (2016-2026)
7.3 Europe IL-12 Antibody Market Size by Country
7.3.1 Europe IL-12 Antibody Revenue by Country (2016-2026)
7.3.2 Germany IL-12 Antibody Market Size and Forecast (2016-2026)
7.3.3 France IL-12 Antibody Market Size and Forecast (2016-2026)
7.3.4 United Kingdom IL-12 Antibody Market Size and Forecast (2016-2026)
7.3.5 Russia IL-12 Antibody Market Size and Forecast (2016-2026)
7.3.6 Italy IL-12 Antibody Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific IL-12 Antibody Revenue by Type (2016-2026)
8.2 Asia-Pacific IL-12 Antibody Revenue by Application (2016-2026)
8.3 Asia-Pacific IL-12 Antibody Market Size by Region
8.3.1 Asia-Pacific IL-12 Antibody Revenue by Region (2016-2026)
8.3.2 China IL-12 Antibody Market Size and Forecast (2016-2026)
8.3.3 Japan IL-12 Antibody Market Size and Forecast (2016-2026)
8.3.4 South Korea IL-12 Antibody Market Size and Forecast (2016-2026)
8.3.5 India IL-12 Antibody Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia IL-12 Antibody Market Size and Forecast (2016-2026)
8.3.7 Australia IL-12 Antibody Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
9.1 South America IL-12 Antibody Revenue by Type (2016-2026)
9.2 South America IL-12 Antibody Revenue by Application (2016-2026)
9.3 South America IL-12 Antibody Market Size by Country
9.3.1 South America IL-12 Antibody Revenue by Country (2016-2026)
9.3.2 Brazil IL-12 Antibody Market Size and Forecast (2016-2026)
9.3.3 Argentina IL-12 Antibody Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa IL-12 Antibody Revenue by Type (2016-2026)
10.2 Middle East & Africa IL-12 Antibody Revenue by Application (2016-2026)
10.3 Middle East & Africa IL-12 Antibody Market Size by Country
10.3.1 Middle East & Africa IL-12 Antibody Revenue by Country (2016-2026)
10.3.2 Turkey IL-12 Antibody Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia IL-12 Antibody Market Size and Forecast (2016-2026)
10.3.4 UAE IL-12 Antibody Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global IL-12 Antibody Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global IL-12 Antibody Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market IL-12 Antibody Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global IL-12 Antibody Revenue (USD Million) by Region (2016-2021)
Table 5. Global IL-12 Antibody Revenue Market Share by Region (2021-2026)
Table 6. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 7. Thermo Fisher Scientific Major Business
Table 8. Thermo Fisher Scientific IL-12 Antibody Product and Solutions
Table 9. Thermo Fisher Scientific IL-12 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. FineTest Corporate Information, Head Office, and Major Competitors
Table 11. FineTest Major Business
Table 12. FineTest IL-12 Antibody Product and Solutions
Table 13. FineTest IL-12 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Santa Cruz Biotechnology Corporate Information, Head Office, and Major Competitors
Table 15. Santa Cruz Biotechnology Major Business
Table 16. Santa Cruz Biotechnology IL-12 Antibody Product and Solutions
Table 17. Santa Cruz Biotechnology IL-12 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. ProSci Corporate Information, Head Office, and Major Competitors
Table 19. ProSci Major Business
Table 20. ProSci IL-12 Antibody Product and Solutions
Table 21. ProSci IL-12 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Bio X Cell Corporate Information, Head Office, and Major Competitors
Table 23. Bio X Cell Major Business
Table 24. Bio X Cell IL-12 Antibody Product and Solutions
Table 25. Bio X Cell IL-12 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. GeneTex Corporate Information, Head Office, and Major Competitors
Table 27. GeneTex Major Business
Table 28. GeneTex IL-12 Antibody Product and Solutions
Table 29. GeneTex IL-12 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Atlas Antibodies Corporate Information, Head Office, and Major Competitors
Table 31. Atlas Antibodies Major Business
Table 32. Atlas Antibodies IL-12 Antibody Product and Solutions
Table 33. Atlas Antibodies IL-12 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Miltenyi Biotec Corporate Information, Head Office, and Major Competitors
Table 35. Miltenyi Biotec Major Business
Table 36. Miltenyi Biotec IL-12 Antibody Product and Solutions
Table 37. Miltenyi Biotec IL-12 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Proteintech Corporate Information, Head Office, and Major Competitors
Table 39. Proteintech Major Business
Table 40. Proteintech IL-12 Antibody Product and Solutions
Table 41. Proteintech IL-12 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. United States Biological Corporate Information, Head Office, and Major Competitors
Table 43. United States Biological Major Business
Table 44. United States Biological IL-12 Antibody Product and Solutions
Table 45. United States Biological IL-12 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. BioLegend Corporate Information, Head Office, and Major Competitors
Table 47. BioLegend Major Business
Table 48. BioLegend IL-12 Antibody Product and Solutions
Table 49. BioLegend IL-12 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. NSJ Bioreagents Corporate Information, Head Office, and Major Competitors
Table 51. NSJ Bioreagents Major Business
Table 52. NSJ Bioreagents IL-12 Antibody Product and Solutions
Table 53. NSJ Bioreagents IL-12 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global IL-12 Antibody Revenue (USD Million) by Players (2019-2021)
Table 55. Global IL-12 Antibody Revenue Share by Players (2019-2021)
Table 56. Breakdown of IL-12 Antibody by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. IL-12 Antibody Players Head Office, Products and Services Provided
Table 58. IL-12 Antibody Mergers & Acquisitions in the Past Five Years
Table 59. IL-12 Antibody New Entrants and Expansion Plans
Table 60. Global IL-12 Antibody Revenue (USD Million) by Type (2016-2021)
Table 61. Global IL-12 Antibody Revenue Share by Type (2016-2021)
Table 62. Global IL-12 Antibody Revenue Forecast by Type (2021-2026)
Table 63. Global IL-12 Antibody Revenue by Application (2016-2021)
Table 64. Global IL-12 Antibody Revenue Forecast by Application (2021-2026)
Table 65. North America IL-12 Antibody Revenue by Type (2016-2021) & (USD Million)
Table 66. North America IL-12 Antibody Revenue by Type (2021-2026) & (USD Million)
Table 67. North America IL-12 Antibody Revenue by Application (2016-2021) & (USD Million)
Table 68. North America IL-12 Antibody Revenue by Application (2021-2026) & (USD Million)
Table 69. North America IL-12 Antibody Revenue by Country (2016-2021) & (USD Million)
Table 70. North America IL-12 Antibody Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe IL-12 Antibody Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe IL-12 Antibody Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe IL-12 Antibody Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe IL-12 Antibody Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe IL-12 Antibody Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe IL-12 Antibody Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific IL-12 Antibody Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific IL-12 Antibody Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific IL-12 Antibody Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific IL-12 Antibody Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific IL-12 Antibody Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific IL-12 Antibody Revenue by Region (2021-2026) & (USD Million)
Table 83. South America IL-12 Antibody Revenue by Type (2016-2021) & (USD Million)
Table 84. South America IL-12 Antibody Revenue by Type (2021-2026) & (USD Million)
Table 85. South America IL-12 Antibody Revenue by Application (2016-2021) & (USD Million)
Table 86. South America IL-12 Antibody Revenue by Application (2021-2026) & (USD Million)
Table 87. South America IL-12 Antibody Revenue by Country (2016-2021) & (USD Million)
Table 88. South America IL-12 Antibody Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa IL-12 Antibody Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa IL-12 Antibody Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa IL-12 Antibody Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa IL-12 Antibody Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa IL-12 Antibody Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa IL-12 Antibody Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. IL-12 Antibody Picture
Figure 2. Global IL-12 Antibody Revenue Market Share by Type in 2020
Figure 3. Polyclonal
Figure 4. Monoclonal
Figure 5. IL-12 Antibody Revenue Market Share by Application in 2020
Figure 6. Flow Cytometry Picture
Figure 7. Immunoprecipitation Picture
Figure 8. Western Blot Picture
Figure 9. Others Picture
Figure 10. Global IL-12 Antibody Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global IL-12 Antibody Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global IL-12 Antibody Revenue Market Share by Region (2016-2026)
Figure 13. Global IL-12 Antibody Revenue Market Share by Region in 2020
Figure 14. North America IL-12 Antibody Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe IL-12 Antibody Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific IL-12 Antibody Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America IL-12 Antibody Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa IL-12 Antibody Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. IL-12 Antibody Market Drivers
Figure 20. IL-12 Antibody Market Restraints
Figure 21. IL-12 Antibody Market Trends
Figure 22. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 23. FineTest Recent Developments and Future Plans
Figure 24. Santa Cruz Biotechnology Recent Developments and Future Plans
Figure 25. ProSci Recent Developments and Future Plans
Figure 26. Bio X Cell Recent Developments and Future Plans
Figure 27. GeneTex Recent Developments and Future Plans
Figure 28. Atlas Antibodies Recent Developments and Future Plans
Figure 29. Miltenyi Biotec Recent Developments and Future Plans
Figure 30. Proteintech Recent Developments and Future Plans
Figure 31. United States Biological Recent Developments and Future Plans
Figure 32. BioLegend Recent Developments and Future Plans
Figure 33. NSJ Bioreagents Recent Developments and Future Plans
Figure 34. Global IL-12 Antibody Revenue Share by Players in 2020
Figure 35. IL-12 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players IL-12 Antibody Revenue Market Share in 2020
Figure 37. Global Top 10 Players IL-12 Antibody Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global IL-12 Antibody Revenue Share by Type in 2020
Figure 40. Global IL-12 Antibody Market Share Forecast by Type (2021-2026)
Figure 41. Global IL-12 Antibody Revenue Share by Application in 2020
Figure 42. Global IL-12 Antibody Market Share Forecast by Application (2021-2026)
Figure 43. North America IL-12 Antibody Sales Market Share by Type (2016-2026)
Figure 44. North America IL-12 Antibody Sales Market Share by Application (2016-2026)
Figure 45. North America IL-12 Antibody Revenue Market Share by Country (2016-2026)
Figure 46. United States IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe IL-12 Antibody Sales Market Share by Type (2016-2026)
Figure 50. Europe IL-12 Antibody Sales Market Share by Application (2016-2026)
Figure 51. Europe IL-12 Antibody Revenue Market Share by Country (2016-2026)
Figure 52. Germany IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific IL-12 Antibody Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific IL-12 Antibody Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific IL-12 Antibody Revenue Market Share by Region (2016-2026)
Figure 60. China IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America IL-12 Antibody Sales Market Share by Type (2016-2026)
Figure 67. South America IL-12 Antibody Sales Market Share by Application (2016-2026)
Figure 68. South America IL-12 Antibody Revenue Market Share by Country (2016-2026)
Figure 69. Brazil IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa IL-12 Antibody Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa IL-12 Antibody Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa IL-12 Antibody Revenue Market Share by Country (2016-2026)
Figure 74. Turkey IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE IL-12 Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Thermo Fisher Scientific
FineTest
Santa Cruz Biotechnology
ProSci
Bio X Cell
GeneTex
Atlas Antibodies
Miltenyi Biotec
Proteintech
United States Biological
BioLegend
NSJ Bioreagents
jiaGou

Add To Cart

gouMai

Buy Now